BioSpace News Archive

BioCapital

American Diabetes Association® Deeply Concerned About New Guidance from American College of Physicians Regarding Blood Glucose Targets for People with Type 2 Diabetes

The American Diabetes Association is deeply concerned by the new guidance, “Hemoglobin A1C Targets for Glycemic Control with Pharmacologic Therapy for Nonpregnant Adults with Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians,” published in the Annals of Internal Medicine on March 5, 2018.

March 8, 2018
·
4 min read
FDA

Pfizer Announces Favorable Outcome of FDA Advisory Committee Meeting on XELJANZ® (tofacitinib) for Moderately to Severely Active Ulcerative Colitis

Pfizer Inc. announced a positive outcome from today’s U.S. Food and Drug Administration (FDA) Gastrointestinal Drugs Advisory Committee (GIDAC) meeting.

March 8, 2018
·
14 min read
BioMidwest

Option Care Selected as the Home and Alternate Site Infusion Provider for Newly Approved Breakthrough Therapy, Trogarzo™ (ibalizumab-uiyk) Injection

Option Care Enterprises, Inc. has been selected by Theratechnologies Inc. as an infusion provider for Trogarzo™ (ibalizumab-uiyk) Injection, an intravenous (IV) infusion for the treatment of multidrug resistant human immunodeficiency virus type 1 (HIV-1) infections.

March 8, 2018
·
3 min read
BioMidwest

Zimmer Biomet Prices Offering of Senior Notes

Zimmer Biomet Holdings Inc. announced that it has priced an offering of $450 million principal amount of its floating rate senior unsecured notes due 2021 and $300 million principal amount of its 3.700% senior unsecured notes due 2023.

March 8, 2018
·
1 min read
Job Trends

Metactive Medical Raises $1.2 Million of Additional Capital and Awarded $1.5 Million Grant from the National Institutes of Health

Metactive Medical Inc. announced it has closed an additional $1.2 million in Series A financing from a group of investors, including Mid-America Angels and Serra Ventures, bringing the total funding raised to date more than $10 million.

March 8, 2018
·
2 min read
Business

Catabasis Pharmaceuticals to Report Fourth Quarter and Full Year 2017 Financial Results and Recent Corporate Developments on Thursday, March 15

The Company will Host a Conference Call at 4:30pm ET

March 8, 2018
·
1 min read
Business

Charles River Laboratories Makes Expansions to Global Biologics Infrastructure

The Company is adding Devon Park, doubling its laboratory footprint in Penn.

March 8, 2018
·
5 min read
FDA

InVivo Therapeutics Receives FDA Approval for Pivotal, Randomized, Controlled Trial of the Neuro-Spinal Scaffold™ in Patients with Acute Spinal Cord Injury

Study Designed to Enhance Clinical Evidence from INSPIRE Study and Support Potential Humanitarian Device Exemption (HDE) Submission

March 8, 2018
·
4 min read
Business

Nimbus Therapeutics Announces Departure of Chief Scientific Officer Rosana Kapeller, M.D., Ph.D.

Nimbus Therapeutics, a biotechnology company applying deep computational expertise throughout drug discovery and development, announced today that Rosana Kapeller has resigned from the company after more than eight years of success to explore an executive leadership role.

March 8, 2018
·
2 min read
Business

HemaCare Reports Full Year 2017 Results

HemaCare Corporation announced operational highlights and financial results for the year ended December 31, 2017.

March 8, 2018
·
2 min read